Corporate Presentation – FY2021 Results 2021 Announcements . Corporate . Financial . Presentation . Regulatory 26.08.2021
Appendix 4E and Preliminary Financial Report 2021 Announcements . Corporate . Financial . Regulatory 26.08.2021
CLINUVEL Delivers Record Revenues and Profit 2021 Announcements . Corporate . Financial . Regulatory 26.08.2021
Insider Insights III: Willem Blijdorp – Challenges & the Future 2021 Announcements . Corporate . News . Presentation . Stories 14.07.2021
Insider Insights II: Willem Blijdorp – CLINUVEL’s Products, People & Social Purpose 2021 Announcements . Corporate . News . Presentation . Stories 07.07.2021
Insider Insights: Willem Blijdorp – Chair of The CLINUVEL Group 2021 Announcements . Corporate . News . Presentation . Stories 30.06.2021
Media Release – CLINUVEL Expands DNA Repair Program 2021 Announcements . Clinical . Corporate . News 24.03.2021
SCENESSE® To Be Evaluated in Xeroderma Pigmentosum Variant (XPV) 2021 Announcements . Clinical . Corporate . Regulatory 24.03.2021
SCENESSE® Granted Market Access In Israel 2021 Announcements . Clinical . Corporate . Regulatory 11.02.2021